Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Vera Therapeutics' (VERA) Shares Are Still Undervalued - Cantor Fitzgerald
-
Zscaler's (ZS) Top-Line Growth Shows Impressive Execution - Cantor Fitzgerald
-
CleanSpark (CLSK) PT Lowered to $21 at Cantor Fitzgerald: Still Attractive
-
Ascendis Pharma's (ASND) PDUFA Extension a Minor Issue - Cantor Fitzgerald
-
Workday's (WDAY) Subscription Revenue Beat Relatively Skinny - Cantor Fitzgerald
-
Avino Silver & Gold files prospectus for $60M share offering program
-
Avino Renews ATM Equity Program
-
RecycLiCo Adds Rob Chang to Proposed Board of Directors
-
HIVE Digital launches $300 million at-the-market equity program
-
HIVE Digital Announces At-The-Market Equity Program
-
Salesforce.com (CRM) Will Post Solidm Uneventful F3Q Results - Cantor Fitzgerald
-
Agios Pharma (AGIO) Management Sees a Path to Profitability - Cantor Fitzgerald
-
Symbotic (SYM) PT Raised to $82 at Cantor Fitzgerald on Continued Execution
-
Zoom Video (ZM) Will Benefit from Shift to Digital Collab, AI - Cantor Fitzgerald
-
VIZSLA SILVER closes $300 million convertible notes offering
-
VIZSLA SILVER ANNOUNCES CLOSING OF US$300 MILLION CONVERTIBLE SENIOR NOTES OFFERING
-
Nuvalent completes $500 million stock offering with underwriters' option
-
Nuvalent Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares from Selling Stockholders
-
AleraCare and Pure Healthcare Complete Merger, Creating a Leading National Platform for Ambulatory Infusion and Specialty Care
-
Cantor Fitzgerald Reiterates Overweight Rating on DoorDash Inc. (DASH)
-
Cantor Fitzgerald Reiterates Neutral Rating on Fortinet (FTNT)
-
Vertical Aerospace (EVTL) Has Considerable Upside - Cantor Fitzgerald
-
Eve Holding (EVEX) Will Drive Capex, Cash Burn Lower then Peers - Cantor Fitzgerald
-
Archer Aviation (ACHR) On-Track for 3Q26 UAE Certification - Cantor Fitzgerald
-
Palo Alto Networks (PANW) 'Plays the Long Game' - Cantor Fitzgerald
-
Bristol-Myers Squibb's (BMY) Milvexian Can Reset Sentiment - Cantor Fitzgerald
-
Bristol-Myers Squibb's (BMY) Milvexian Can Reset Sentiment Positively - Cantor Fitzgerald
-
Okta (OKTA) PT Lowered to $115 at Cantor Fitzgerald: There's Upside Potential
-
SentinelOne (S) PT Lowered to $22 at Cantor Fitzgerald on Recent Market Contraction
-
Cantor Fitzgerald Assumes Belite Bio, Inc, ADR (BLTE) at Overweight
-
Soulpower agrees to merge with SWB in $8.1 billion deal
-
Soulpower Acquisition Corporation (NYSE:SOUL) Announces Signing of Business Combination Agreement for Business Combination with SWB LLC Currently Valued at Approximately $8.1 Billion to Launch New Eco
-
Securitize to Host Webcast to Review Proposed Business Combination with Cantor Equity Partners II
-
Cantor Fitzgerald Reiterates Overweight Rating on Ultragenyx Pharma (RARE)
-
PebbleBrook's (PEB) Sale of Montrose Could Help Reduce Leverage -Cantor Fitzgerald
-
Pharvaris B.V. (PHVS) Stock Setup is Strong - Cantor Fitzgerald
-
Septerna's (SEPN) Novo Pursuing a Multi-Billion-Dollar Opportunity- Cantor Fitzgerald
-
AIRO Group (AIRO) PT Lowered to $20 at Cantor Fitzgerald After Disappointing 3Q
-
Elastic NV. (ESTC) PT Lowered to $85 at Cantor Fitzgerald: Steady Acceleration Awaited
-
Inhibikase prices $100 million stock offering at $1.45 per share
-
Inhibikase Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock and Pre-Funded Warrants
-
Inhibikase Therapeutics announces public offering of stock
-
Inhibikase Therapeutics announces public offering of stock
-
Inhibikase Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
-
Dubai to Host Senior Energy Leaders for the Middle East Gas Conference
-
Nanox Announces Third Quarter of 2025 Financial Results and Provides Business Update
-
Agios Pharma's (AGIO) Regulatory Path in the Air - Cantor Fitzgerald
-
Workday (WDAY) 'Valuation is Very Approachable' - Cantor Fitzgerald
-
Regeneron Pharma (REGN) Shares Are Almost Back to Positive - Cantor Fitzgerald
-
NVIDIA (NVDA) 'Remains Our Top Pick' - Cantor Fitzgerald

